fda glp-1 compounding warning october 2025 issued 25 letters to telehealth companies for false and misleading claims about compounded products. Unlike FDA-approved drugs, these products have not been proven to be safe, effective, or of The Refill, Issue 13: FDA

doi: 10.3390/IJMS131013065 77 SinghAKYadavDSharmaNJinJO

Sen and study co-authors, associate professor Dr Nadia Hernandez, and assistant professor Dr Christina Goehl, who are subspecialised anaesthesiologists with expertise in point-of-care ultrasound that allows bedside assessment of stomach contents

doi: 10.1038/s41392-022-01149-x

Key difference from GLP-1s: Doesn't suppress appetite

These limitations do not invalidate the findings, but they do mean that the evidence is preliminary rather than definitive

Always consult your healthcare provider before starting a new supplement, particularly if you are pregnant, nursing, or taking medication.